      Document 0009
 DOCN  DRG0009
 UNIQUE IDENTIFIER        DRG-0238
 NAME OF SUBSTANCE        A-007 [FDA 247A]
 STANDARD CHEMICAL NAME   4,4'-Dihydroxybenzophenone-2,4-dinitrophenylh-
                          ydrazone [FDA 247A]
 PROTOCOL ID NUMBERS      FDA 247A
 SECONDARY SOURCE ID      DRG
 DISEASES STUDIED/TREATED Cutaneous lesions from Kaposi's sarcoma and
                          lymphoproliferative disorders [FDA 247A]
 CLASSIFICATION CODE      Antineoplastic [FDA 247A]
 SUBSTANCE DELIVERY DATA  DOSAGE FORM: 0.25% gel. [FDA 247A]
 SUBSTANCE DELIVERY DATA  MODE OF DELIVERY: Topical. [FDA 247A]
 MANUFACTURERS            DEKK-TEC Inc
 ENTRY MONTH              9511
 LAST REVISION DATE       951129
 

SOURCE: National Library of Medicine, Bethesda, MD.  Distributed by AEGIS.
